Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of MedEquities Realty Trust, Inc. (“MedEquities” or the “Company”)(NYSE: MRT) to Omega Healthcare Investors, Inc. (NYSE: OHI). Under the terms of the transaction, MedEquities shareholders will receive 0.235 Omega common shares plus $2.00 in cash for each common share of MedEquities stock they own. Based on the closing price of Omega stock on December 31, 2018, this represents a value of approximately $10.26 per share.
The MedEquities merger investigation concerns whether the Board of MedEquities breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Omega is underpaying for MedEquities shares, thus unlawfully harming MedEquities shareholders.
To receive more information, please fill out the form.